Phase 1 Study of SBS-147 in Healthy Adults

Part of paid clinical trials in Cypress, California.

Sponsor
Sparian Biosciences, Inc
Study ID
NCT07335913
Phase
PHASE1
Status
Recruiting
Apply to this trial

Conditions

  • Pain
  • Pain Acute

Eligibility Criteria

Sex
ALL
Age
18 Years - 55 Years
Healthy Volunteers
Accepted

Interventions

  • SBS-147 — DRUG
    Experimental therapeutic
  • Placebo — DRUG
    Placebo comparator

Study Details

This study is part of the HEAL Initiative supported by the NIH. The purpose of this study is to learn how safe the study drug, SBS-147, is and how people's bodies respond to and process it. Researchers will also look for any side effects that may occur when taking SBS-147. Some participants will receive SBS-147, and others will receive a placebo, which looks the same but does not contain any medicine. This helps researchers fairly compare results. The study includes two parts: Single-Dose Group, where Participants receive SBS-147 or placebo one time. Multiple-Dose Group, where Participants receive SBS-147 or placebo once or twice daily for 7 days.

Key Dates

Start date
Jan 8, 2026
Status verified
Feb 2026
Primary completion
Jan 31, 2027
Completion
Feb 28, 2027

Study Design

Enrollment
80 participants (estimated)
Allocation
RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
TREATMENT

Arms

  • Experimental: Single Ascending Dose
    Single dose of SBS-147 or a placebo given during trial
  • Experimental: Multiple Ascending Dose
    SBS-147 or placebo given repeatedly over several days during the trial

Primary Outcome Measure

Number of participants with treatment-related adverse events as assessed by CTCAE v5.0 [ Time Frame: 8 days ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
AltaSciences, IncCypressCalifornia90630
David Nguyen, MD
[email protected]
913 696-1601

Find similar trials in Cypress, CA

By research site
AltaSciences, Inc· Cypress, CA

Related Studies